Cargando…
Novel STAT3 Inhibitor LDOC1 Targets Phospho-JAK2 for Degradation by Interacting with LNX1 and Regulates the Aggressiveness of Lung Cancer
Meta-analysis revealed that Leucine Zipper Down-Regulated In Cancer 1 (LDOC1) increased methylation more in people with lung tumors than in those who were healthy and never smoked. Quantitative methylation-specific PCR revealed that cigarette smoke condensate (CSC) exposure drives LDOC1 promoter hyp...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356782/ https://www.ncbi.nlm.nih.gov/pubmed/30634502 http://dx.doi.org/10.3390/cancers11010063 |
_version_ | 1783391635309068288 |
---|---|
author | Lee, Chia-Huei Yang, Ji-Rui Chen, Chih-Yu Tsai, Ming-Hsien Hung, Pin-Feng Chen, Shin-Jih Chiang, Shang-Lun Chang, Han Lin, Pinpin |
author_facet | Lee, Chia-Huei Yang, Ji-Rui Chen, Chih-Yu Tsai, Ming-Hsien Hung, Pin-Feng Chen, Shin-Jih Chiang, Shang-Lun Chang, Han Lin, Pinpin |
author_sort | Lee, Chia-Huei |
collection | PubMed |
description | Meta-analysis revealed that Leucine Zipper Down-Regulated In Cancer 1 (LDOC1) increased methylation more in people with lung tumors than in those who were healthy and never smoked. Quantitative methylation-specific PCR revealed that cigarette smoke condensate (CSC) exposure drives LDOC1 promoter hypermethylation and silence in human bronchial cells. Immunohistochemistry studies showed that LDOC1 downregulation is associated with poor survival of patients with lung cancer. Loss and gain of LDOC1 functions enhanced and attenuated aggressive phenotypes in lung adenocarcinoma A549 and non–small cell lung carcinoma H1299 cell lines, respectively. We found that LDOC1 deficiency led to reinforcing a reciprocal loop of IL-6/JAK2/STAT3, through which LDOC1 mediates the cancer progression. LDOC1 knockdown considerably augmented tumorigenesis and the phosphorylation of JAK2 and STAT3 in vivo. Results from immunoprecipitation and immunofluorescent confocal microscopy indicated that LDOC1 negatively regulates JAK2 activity by forming multiple protein complexes with pJAK2 and E3 ubiquitin-protein ligase LNX1, and in turn, LDOC1 targets pJAK2 to cause ubiquitin-dependent proteasomal degradation. LDOC1 deficiency attenuates the interactions between LNX1 and pJAK2, leading to ineffective ubiquitination of pJAK2, which activates STAT3. Overall, our results elucidated a crucial role of LDOC1 in lung cancer and revealed how LDOC1 acts as a bridge between tobacco exposure and the IL-6/JAK2/STAT3 loop in this human malignancy. |
format | Online Article Text |
id | pubmed-6356782 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-63567822019-02-05 Novel STAT3 Inhibitor LDOC1 Targets Phospho-JAK2 for Degradation by Interacting with LNX1 and Regulates the Aggressiveness of Lung Cancer Lee, Chia-Huei Yang, Ji-Rui Chen, Chih-Yu Tsai, Ming-Hsien Hung, Pin-Feng Chen, Shin-Jih Chiang, Shang-Lun Chang, Han Lin, Pinpin Cancers (Basel) Article Meta-analysis revealed that Leucine Zipper Down-Regulated In Cancer 1 (LDOC1) increased methylation more in people with lung tumors than in those who were healthy and never smoked. Quantitative methylation-specific PCR revealed that cigarette smoke condensate (CSC) exposure drives LDOC1 promoter hypermethylation and silence in human bronchial cells. Immunohistochemistry studies showed that LDOC1 downregulation is associated with poor survival of patients with lung cancer. Loss and gain of LDOC1 functions enhanced and attenuated aggressive phenotypes in lung adenocarcinoma A549 and non–small cell lung carcinoma H1299 cell lines, respectively. We found that LDOC1 deficiency led to reinforcing a reciprocal loop of IL-6/JAK2/STAT3, through which LDOC1 mediates the cancer progression. LDOC1 knockdown considerably augmented tumorigenesis and the phosphorylation of JAK2 and STAT3 in vivo. Results from immunoprecipitation and immunofluorescent confocal microscopy indicated that LDOC1 negatively regulates JAK2 activity by forming multiple protein complexes with pJAK2 and E3 ubiquitin-protein ligase LNX1, and in turn, LDOC1 targets pJAK2 to cause ubiquitin-dependent proteasomal degradation. LDOC1 deficiency attenuates the interactions between LNX1 and pJAK2, leading to ineffective ubiquitination of pJAK2, which activates STAT3. Overall, our results elucidated a crucial role of LDOC1 in lung cancer and revealed how LDOC1 acts as a bridge between tobacco exposure and the IL-6/JAK2/STAT3 loop in this human malignancy. MDPI 2019-01-09 /pmc/articles/PMC6356782/ /pubmed/30634502 http://dx.doi.org/10.3390/cancers11010063 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lee, Chia-Huei Yang, Ji-Rui Chen, Chih-Yu Tsai, Ming-Hsien Hung, Pin-Feng Chen, Shin-Jih Chiang, Shang-Lun Chang, Han Lin, Pinpin Novel STAT3 Inhibitor LDOC1 Targets Phospho-JAK2 for Degradation by Interacting with LNX1 and Regulates the Aggressiveness of Lung Cancer |
title | Novel STAT3 Inhibitor LDOC1 Targets Phospho-JAK2 for Degradation by Interacting with LNX1 and Regulates the Aggressiveness of Lung Cancer |
title_full | Novel STAT3 Inhibitor LDOC1 Targets Phospho-JAK2 for Degradation by Interacting with LNX1 and Regulates the Aggressiveness of Lung Cancer |
title_fullStr | Novel STAT3 Inhibitor LDOC1 Targets Phospho-JAK2 for Degradation by Interacting with LNX1 and Regulates the Aggressiveness of Lung Cancer |
title_full_unstemmed | Novel STAT3 Inhibitor LDOC1 Targets Phospho-JAK2 for Degradation by Interacting with LNX1 and Regulates the Aggressiveness of Lung Cancer |
title_short | Novel STAT3 Inhibitor LDOC1 Targets Phospho-JAK2 for Degradation by Interacting with LNX1 and Regulates the Aggressiveness of Lung Cancer |
title_sort | novel stat3 inhibitor ldoc1 targets phospho-jak2 for degradation by interacting with lnx1 and regulates the aggressiveness of lung cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356782/ https://www.ncbi.nlm.nih.gov/pubmed/30634502 http://dx.doi.org/10.3390/cancers11010063 |
work_keys_str_mv | AT leechiahuei novelstat3inhibitorldoc1targetsphosphojak2fordegradationbyinteractingwithlnx1andregulatestheaggressivenessoflungcancer AT yangjirui novelstat3inhibitorldoc1targetsphosphojak2fordegradationbyinteractingwithlnx1andregulatestheaggressivenessoflungcancer AT chenchihyu novelstat3inhibitorldoc1targetsphosphojak2fordegradationbyinteractingwithlnx1andregulatestheaggressivenessoflungcancer AT tsaiminghsien novelstat3inhibitorldoc1targetsphosphojak2fordegradationbyinteractingwithlnx1andregulatestheaggressivenessoflungcancer AT hungpinfeng novelstat3inhibitorldoc1targetsphosphojak2fordegradationbyinteractingwithlnx1andregulatestheaggressivenessoflungcancer AT chenshinjih novelstat3inhibitorldoc1targetsphosphojak2fordegradationbyinteractingwithlnx1andregulatestheaggressivenessoflungcancer AT chiangshanglun novelstat3inhibitorldoc1targetsphosphojak2fordegradationbyinteractingwithlnx1andregulatestheaggressivenessoflungcancer AT changhan novelstat3inhibitorldoc1targetsphosphojak2fordegradationbyinteractingwithlnx1andregulatestheaggressivenessoflungcancer AT linpinpin novelstat3inhibitorldoc1targetsphosphojak2fordegradationbyinteractingwithlnx1andregulatestheaggressivenessoflungcancer |